Join
Live feed
·
INSIDERFilingvia Quantisnow
Leap Therapeutics Inc. logo

Chief Manufacturing Officer O'Mahony John Mark converted options into 22,500 shares, increasing direct ownership by 450% to 27,500 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
LPTX· Leap Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LPTX (Leap Therapeutics Inc.) and more on Quantisnow.

Chief Manufacturing Officer O'Mahony John Mark converted options into 22,500 shares, increasing direct ownership by 450% to 27,500 units (SEC Form 4) | Quantisnow